Abstract #2244

Comparison of the diagnostic performance in the HCC with cirrhosis between the 2017 and 2018 versions of LI‑RADS based on Gd‑EOB‑DTPA enhanced MRI

Fei Xing¹, Yi shi Wang², and Xian ce Zhao³

¹the Third Affiliated Nantong Hospital of Nantong University, Nantong, China, ²Philips Healthcare, Beijing, China, ³Philips Healthcare, Shanghai, China

Synopsis

Keywords: Liver, Cancer, HCCThe Liver Imaging Reporting and Data System (LI-RADS) is widely adopted for noninvasive diagnosis of hepatocellular carcinoma (HCC). It’s updated to version 2018 recently, with some major changes compared with v2017.Therefore, the aim of this study was to compare the diagnostic performances of LI-RADS for diagnosing HCC between v2017 and v2018 based on Gd-EOB-DTPA enhanced MRI.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.